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This article will explore the potential pitfalls of using certain claim types for 
protection of computerized systems or devices that include functionality enabled 
software.  Through a demonstration of the potential shortcomings of method 
claims, particularly in the area of damages awarded, it will discuss why a 
computer-readable medium claim may be a good alternative to a standard method 
claim.1  In addition, it will illustrate how a computer-readable medium claim can 
provide a claim scope similar to a method claim without having to prove actual 
use to obtain damages.2   
Attached to the end of this article are three appendices.  Appendix A portrays 
statistical analysis of the use of Beauregard claims, while Appendices B and C 
respectively provide an overview of basic claim types used within patent 
applications and types of patent infringement.  
 
A. Background 
Today’s economy has become very dependent on computer software because 
of the role it plays in nearly everything we do, from simple everyday tasks all the 
way up to our nation’s complex infrastructure.3  The increased reliance on 
computers and computer programs powering electronic devices is accompanied 
by a desire to patent those programs.  Patentability of software has been a sticking 
point for the courts and the United States Patent and Trademark Office 
(“USPTO”) for many years.4  In 1995, the USPTO responded to the emergence of 
computer software and began allowing computer-readable medium claims.5  In 
the years that have followed, however, patents focused on computerized devices 
have often been written by claiming “a process” in what are commonly referred to 
as method claims.6  
                                                                                                                                     
1  See infra text accompanying notes 41-77.  
2  See infra text accompanying notes 54-69. 
3 See, e.g., U.S. CENSUS BUREAU, Internet Use in the United States: October 2009, 
http://www.census.gov/hhes/computer/ (last visited July 18, 2011) (revealing that 68.7% of all 
householders (defined as the person (or one of the persons) in whose name the housing unit is 
owned or rented) reported using the internet at home, and 76.7% reported using the internet from 
some location (either inside or outside the home)). 
4 See Andrei Iancu & Jeremiah Helm, Code on Disks and Hat Tricks – Is Computer Software 
on a Medium Really Patentable?, 90 J. PAT. & TRADEMARK OFF. SOC’Y 97, 97 (2008); see also 
U.S. PATENT & TRADEMARK OFFICE, U.S. DEP’T OF COMMERCE, MPEP § 2106.01 (8th ed. Rev. 8, 
July 2010) (discussing computer-related nonstatutory subject matter). 
5 See In re Beauregard, 53 F.3d 1583 (Fed. Cir. 1995). 
6 See 1 R. CARL MOY, MOY’S WALKER ON PATENTS § 5.35 (4th ed. 2010) (discussing general 
patentability of computer related inventions). 
3
Sharp et al.: Can Beauregard Claims Show You the Money?
Published by Mitchell Hamline Open Access, 2011
[2:25 2011]             CYBARIS®, AN INTELLECTUAL PROPERTY LAW REVIEW 28 
 
Because of the potential for enormous sums of money, the recovery of 
damages has become one of the most important aspects of a patent.7 Since the 
Supreme Court’s decision in eBay, Inc. v. MercExchange, L.L.C.,8 the ability for a 
patent owner to obtain an injunction to stop an infringer from conducting the 
infringing behavior has been limited.9  
Accordingly, patent claims that provide a patent owner the best opportunity to 
recover damages are increasingly important. Recent cases involving computerized 
devices highlight potential pitfalls in relying on claiming methods of operation 
(e.g., method claims) to cover devices or systems.10  In order for a method claim 
to be infringed, all steps of the process must be carried out.11  As a result, patent 
holders may be losing out on a portion of the damages to which they are entitled 
when a device is merely capable of infringement.12  When asserting a method 
claim against a system or device that is capable of infringing, the patent owner 
will only be able to recover damages for those systems or devices shown to have 
actually performed the claimed method.13  In a world of programmable devices, 
those devices that have been programmed to actually perform the claimed method 
may be far fewer than those devices including software providing the capability to 
perform the claimed method.  
Moreover, these issues are not limited only to computer software.  For 
example, medical device manufacturers spend a great deal of time and money 
developing, testing, and marketing products.  Accordingly, strong patent 
protection for unique features of a medical device can help provide competitive 
advantages in this industry.14  Modern medical devices include electromechanical 
devices that can contain embedded software.  In an infringement suit that only 
asserts method claims, the device (e.g., embedded software) must have executed 
the claimed method or it will not have been found to infringe.15 
 
                                                                                                                                     
7 See z4 Techs., Inc. v. Microsoft Corp., 434 F. Supp.2d 437, 438-39 (E.D. Tex. 
2006)(damages of $115 million awarded against Microsoft and $18 million against Autodesk); see 
infra 46-51 and discussion. 
8 547 U.S. 388 (2006).  
9 See Id. at 393.  
10 See Finjan, Inc. v. Secure Computing Corp., 626 F.3d 1197 (Fed. Cir. 2010); Cardiac 
Pacemakers, Inc. v. St. Jude Med., Inc., 576 F.3d 1348 (Fed. Cir. 2009). 
11 See Lucent Techs. v. Gateway, Inc., 580 F.3d 1301, 1317 (Fed. Cir. 2009); see also Joy 
Techs., Inc. v. Flakt, Inc., 6 F.3d 770, 775 (Fed. Cir. 1993). 
12 See Cardiac Pacemakers, Inc., 576 F.3d at 1358-59. 
13 See Lucent Techs., 580 F.3d at 1317. 
14 E.g., the ability to keep a competitor from exploiting the invention or the generate revenue 
through a licensing agreement. 
15 See Cardiac Pacemakers, Inc., 576 F.3d at 1354. 
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II. SHORTCOMINGS OF VARIOUS CLAIMS IN PROTECTING SYSTEMS OR DEVICES 
 Computerized systems or devices have become commonplace in the last 
few decades.  As a result, companies that design and manufacture such devices 
have increasingly sought out patent protection for the computerized aspects of 
these systems or devices.16  An excellent example of computerization can be seen 
in the development of implantable medical devices, such as pacemakers.  A large 
number of medical devices on the market today are a mixture of both hardware 
and software.17  
Patents written to protect the intellectual property embodied within medical 
devices (or any computerized system) typically include a mixture of method and 
system claims.18  It is not uncommon for the method claims to represent, at least 
facially, the broadest scope of coverage.19  By only focusing on method claims to 
protect their intellectual property, device manufacturers may not be protecting 
themselves fully when the patented device is infringed.20  For example, in 
Cardiac, the plaintiff had its damages drastically reduced during an appeal to the 
Federal Circuit in 2009 due to the infringement requirements of method claims.21  
 The dispute between Cardiac and St. Jude centered on an implantable 
cardioverter defibrillator (“ICD”).22  “ICDs are small devices that detect and 
correct abnormal heart rhythms that can be fatal if left untreated.”23  The ICDs are 
implantable cardiac devices that can be programmed to administer different types 
of electrical shocks.24  The patent in question25 claimed a method of heart 
stimulation using an implantable heart stimulator that is capable of detecting heart 
arrhythmias or irregular heart rhythms, and of being programmed to treat the 
arrhythmia through either single or multimode operation.26  
                                                                                                                                     
16 U.S. PATENT & TRADEMARK OFFICE, PATENT TECHNOLOGY MONITORING TEAM (PTMT), 
Patenting by Organizations (2010)(IBM was granted 5,866 patents in 2010 and the Microsoft 
Corporation received 3086 patents.) 
17 An implantable cardioverter defibrillator is one example. See infra discussion notes 22-24  
18 See U.S. Patent No. 4,407,288 (filed Mar. 16, 1981). See infra text accompanying notes 25-
29 
19 E.g., the ‘288 patent at issue in Cardiac where the protection was derived from a method 
claim, and the system claim was dropped. 
20 See Cardiac Pacemakers, Inc., 576 F.3d at 1354. 
21 Id. at 1358. 
22 Id. at 1351. 
23 Id. at 1352. 
24 Id. 
25 U.S. Patent No. 4,407,288 (filed Mar. 16, 1981). 
26 Cardiac Pacemakers, Inc., 576 F.3d at 1352. 
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 The patent was held to be valid and infringed, so the focus turned to a 
determination of damages.27  The district court granted St. Jude's motion to limit 
damages to ICDs that actually performed the claimed steps.28  This is where 
asserting only a method claim fell short.   
Originally the jury was presented with two claims: an apparatus claim, and a 
method claim.29  During litigation, the plaintiff abandoned the apparatus claim.30  
The apparatus claim, if infringed, may have provided the plaintiff with a better 
basis to maintain their original damages award for all devices sold with the 
capability of performing in a manner that infringed the claims.31  However, by 
dropping the assertion of infringement of the apparatus (e.g., system) claim, the 
plaintiff was left with damages limited to only those devices that had actually 
been user-programmed to perform the patented method, rather than damages for 
all devices sold that infringed on the apparatus claim by being user-programmable 
to provide the functionality to infringe the apparatus claim.32  
The plaintiff sought royalties for infringement of its method claim.33  The 
problem that the plaintiff faced was that “a method claim is directly infringed 
only by one practicing the patented method.”34  Additionally, the court held that 
“the sale of the apparatus is not the sale of the method.  A method claim is 
directly infringed only by one practicing the patented method.”35  As a result, the 
plaintiff was unable to retain damages for royalties on those devices that were 
sold and merely capable of completing the process.36  The damages finally 
                                                                                                                                     
27 Id. at 1351.   
28 Cardiac Pacemakers, Inc. v. St. Jude Med., Inc., 418 F.Supp.2d 1021, 1040 (S.D. Ind. 
2006). 
29 Cardiac Pacemakers, Inc., 576 F.3d at 1358. 
30 See Cardiac Pacemakers, Inc. v. St. Jude Med., Inc., 381 F.3d 1371, 1380-83 (Fed. Cir. 
2004). Cardiac had originally asserted two claims in the 4,407,288 patent.  Id.  The jury initially 
returned a verdict of valid claims that were not infringed by St. Jude.  Id.  Cardiac only appealed 
the method claim arguing that it was incorrectly construed and the jury was therefore given 
improper instructions with respect to infringement.  Id.  At this point in the trial, Cardiac 
discontinued pursuit of the apparatus claim.  Id. 
31 See Cardiac Pacemakers Inc., 576 F.3d at 1358.  
32 Id. 
33 Id. at 1359. 
34 Id. at 1359 (citing Joy Techs. v. Flakt, Inc., 6 F.3d 770 (Fed. Cir. 1993)).  In Joy 
Technologies the court held that sales of equipment capable of performing a patented process were 
not direct infringement.  Id. at 744-75.  Method patents used in areas other than software must 
fulfill the same requirements.  Sale of equipment capable of performing a process is only an issue 
when that process is actually executed since it is the process, not the apparatus that is patented.  Id. 
35 Joy Techs., 6 F.3d at 775. 
36 Cardiac Pacemakers, Inc., 576 F.3d at 1366. 
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obtained by the plaintiff were limited to those devices that actually performed the 
patented method during the relevant infringement period.37  
It is interesting to note that the apparatus claim was not pursued on appeal in 
Cardiac.38  It is not entirely clear from the case history why this is so, but the 
petitioner’s brief on appeal only requests the court to either apply the jury’s 
damage award or allow for a new trial due to the incorrect interpretation of claim 
4 (a method claim) of the ‘288 Patent.39 The petitioners did not discuss any issue 
with the apparatus claim.40  Potentially this could result from the fact that even 
though the software of the accused devices may have infringed the hardware, the 
defendant's manufactured product did not meet the limitations of claim 13 of the 
‘288 patent. 
III. BEAUREGARD CLAIMS AS AN ALTERNATIVE 
 Beauregard claims are a viable alternative to method and apparatus claims 
for protection of intellectual property embodied within computerized systems or 
devices.  Recent Federal Circuit decisions provide legitimacy to assertion of 
Beauregard claims as well as areas of caution with using Beauregard claims for 
protection of computerized systems and devices (e.g., medical devices).41 
A. Successful Assertion of a Beauregard Claim 
 Beauregard claims can be included in a patent to provide protection for 
computerized systems or devices by claiming executable instructions contained 
on a computer-readable medium that cause the system or device to perform a 
certain function.42 As a result, the patent holder can pursue infringement charges 
against other manufacturers as direct infringers without having to show actual 
use.43  Additionally, the patentee can recover damages from the manufacturer for 
sales of the actual system or device that directly infringe without having to prove 
indirect infringement (i.e., where a user must perform the claimed method).44  By 
using a Beauregard claim instead of an apparatus claim, the patent holder can 
                                                                                                                                     
37 See id. at 1359. 
38 See id. at 1380-83. 
39 Brief of Plaintiff-Appellant at 55, Cardiac Pacemakers, Inc. v. St. Jude Med., Inc., 381 F.3d 
1371 (Fed. Cir. 2004) (Nos. 02-1532, 02-1559). 
40  See id. 
41 See infra text accompanying notes 42-95. 
42 See, e.g., Ex parte Bo Li, No. 2008-1213 (B.P.A.I. Nov. 6, 2008) (finding a typical 
Beauregard claim to be statutory subject matter). 
43 Finjan, Inc. v. Secure Computing Corp., 626 F.3d 1197 (Fed. Cir. 2010). 
44 Id. at 1212.  
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focus on proving functionality not proving that an infringing device includes 
structure analogous to the structure recited by an apparatus claim.45  
In 2007, the Federal Circuit affirmed a jury verdict that granted z4 
Technologies, Inc. (“z4”) $115 million in damages against the Microsoft 
Corporation (“Microsoft”) and $18 million in damages against Autodesk, Inc. 
(“Autodesk”).46  One of the claims asserted by z4 was the Beauregard claim 
reproduced below.47  z4 accused both Microsoft and Autodesk of infringing claim 
32 of United States Patent 6,044,471.48 The claim states:  
A computer readable storage medium having data stored therein 
representing software executable by a computer, the software 
including instructions to reduce use of the software by 
unauthorized users, the storage medium comprising: instructions 
for requiring a password associated with the software; instructions 
for enabling the software after the password has been 
communicated to the software; instructions for subsequently 
requiring a new password to be communicated to the software for 
continued operation of the software; and instructions for 
automatically contacting an authorized representative of the 
software to communicate registration information and obtaining 
authorization for continued operation of the software.49  
This is a prototypical Beauregard claim, as evidenced by the language at the 
preamble of the claim.  During the jury trial, the jury returned a verdict of willful 
infringement by Microsoft and Autodesk and awarded damages of $115 million 
and $18 million respectively.50  Microsoft challenged the validity of the patents, 
but the district court held them to be valid and enforceable.51  The court's finding 
that the '471 Patent was valid and enforceable supported the notion that 
Beauregard claims are a valid tool in writing claims for patents that include 
software.52  The validity of Beauregard claims do not appear to have been 
                                                                                                                                     
45 Id. at 1205. 
46 z4 Techs., Inc. v. Microsoft Corp., 507 F.3d 1340, 1356 (Fed. Cir. 2007). 
47 Id. at 1345.  
48 U.S. Patent No. 6,044,471 (filed June 4, 1998). 
49 Id. 
50 z4 Techs., Inc., 507 F.3d at 1346. 
51 Id. 
52 See id.; see also Creative Internet Advert. Corp. v. Yahoo! Inc., No. 6:0704354, 2009 WL 
2382132, at *1 (E.D. Tex. 2009).   The Creative Internet Advertising Corp. asserted infringement 
by Yahoo! Inc. of claim 45 of U.S. Patent 6,205,432 (filed Nov. 16, 1998) which was a 
Beauregard-style claim.  Id. at *1.  The U.S. District Court for the Eastern District of Texas 
upheld the jury verdict.  Id.  
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seriously disputed within the courts since being recognized as statutory subject 
matter by the USPTO in 1995.53  
 In a more recent case, Finjan, Inc. v. Secure Computing Corp., the Federal 
Circuit upheld a jury finding of infringement for the sale of software that was 
capable of infringing, even though the infringing features were disabled.54  In 
Finjan, the plaintiff sued for infringement of United States Patents Nos. 6,092,194 
(“’194 Patent”),55 6,804,780 (“’780 Patent”),56 and 7,058,822 (“’822 Patent”).57  
Each of the patents contains both method and system claims.  In addition, the ‘780 
Patent and the ‘194 Patent include computer-readable storage medium claims.58  
In a jury trial, the district court held that the defendant willfully infringed all 
asserted claims of the plaintiff’s patents.59  The defendant sold three allegedly 
infringing products, each of which included multiple modules that required the 
separate purchase of an activation key by the end-user.60  The defense argued that 
its software, as delivered, did not infringe because the potentially infringing 
software was not activated.61  However, the Federal Circuit disagreed, at least in 
regard to the system and computer-readable storage medium claims asserted by 
the plaintiff.62  For example, claim 65 of the ‘194 Patent recited a computer-
readable storage medium.63  The Federal Circuit stated that there was nothing in 
the statement of claim 65 that “require[s] program code be ‘active’, only that it be 
written ‘for causing’ a server (‘194 patent claim 65) . . . to perform certain 
steps.”64  The Federal Circuit made it quite clear that the deciding question is 
whether the capability is present within the code, not whether that code is actually 
active or even used.65  
 By asserting Beauregard-style claims, the plaintiff in Finjan was able to 
secure a finding of direct infringement simply by convincing the jury that the 
defendant shipped software that included the capability of performing infringing 
                                                                                                                                     
53 See In re Beauregard, 53 F.3d 1583, 1584 (Fed. Cir. 1995). A check of cases citing to this 
case reveals only three cases as of the date this article was written. 
54 626 F.3d 1197, 1203-1205 (Fed. Cir. 2010). 
55 U.S. Patent No. 6,092,194 (filed Nov. 6, 1997). 
56 U.S. Patent No. 6,804,780 (filed Mar. 30, 2000). 
57 U.S. Patent No. 7,058,822 (filed May 17, 2001). 
58 Finjan, 626 F.3d at 1201. 
59 Id. at 1200. 
60 Id. at 1202. 
61 Id. at 1203. 
62 Id. at 1203-05. 
63 Id. at 1205. See also U.S. Patent No. 6,092,194 cl. 65 (filed Nov. 6, 1997) (claiming a 
“computer-readable storage medium storing program code for causing a server that serves as a 
gateway to a client to perform the steps of . . . .”). 
64 Finjan, 626 F.3d at 1205. 
65 Id. 
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functions.66  In reference to both system and computer-readable medium claims, 
the Court stated “we have held that, to infringe a claim that recites capability and 
not actual operation, an accused device ‘need only be capable of operating’ in the 
described mode.”67  Additionally, the Federal Circuit held that “an accused device 
may be found to infringe if it is reasonably capable of satisfying the claim 
limitations, even though it may also be capable of noninfringing modes of 
operation.”68  The Finjan decision, which was approximately six months old at 
the time of this writing, is further proof that Beauregard-type claims can provide 
enhanced protection for computerized systems or devices when compared to an 
equivalent method claim.  
As noted within the Finjan case, apparatus claims can also be successfully 
asserted against devices or systems that are merely capable of infringing.69  
However, apparatus claims must include structural or means-plus-function 
elements that limit application of the claim to potentially infringing devices.70  
For example, it would appear from the history of the Cardiac case, discussed 
above,71 that the originally asserted apparatus claim included some form of 
structure not necessarily present in the accused devices.72 If an apparatus claim is 
written in means-plus-function form, the claim itself can be, at least facially, 
focused on functional operations.73  However, it is well known that means-plus-
function claims are narrowly construed to only cover the structure (and 
equivalents) discussed within the specification as being capable of performing the 
recited functional operations.74  Thus, apparatus claims are limited by structure, 
while method and Beauregard type claims need not be so limited.  
 Medical devices such as the ICDs that were at issue in Cardiac75 typically 
contain memory with embedded software code. The memory that is contained in 
the medical device is a medium upon which computer executable code is being 
                                                                                                                                     
66 Id.  
67 Id. at 1204 (citing Intel Corp. v. U.S. Int’l Trade Comm’n, 946 F.2d 821, 832 (Fed. Cir. 
1991)). 
68 Finjan, 626 F.3d at 1204 (citing Hilgraeve Corp. v. Symantec Corp., 265 F.3d 1336, 1343 
(Fed. Cir. 2001)). 
69 See Finjan, 626 F.3d at 1203-05. 
70 Id. 
71 Supra text accompanying notes 21-40. 
72 Id. See also generally Cardiac Pacemakers, Inc. v. St. Jude Med., Inc., 381 F.3d 1371, 
1380-83 (Fed. Cir. 2004); Brief of Plaintiff-Appellant at 55, Cardiac Pacemakers, Inc. v. St. Jude 
Med., Inc., 381 F.3d 1371 (Fed. Cir. 2004) (Nos. 02-1532, 02-1559).  This case is used as an 
example only.  The record does not clarify the exact reasons for not pursuing the apparatus claim. 
73 Cite – or provide example 
74 See 35 U.S.C. § 112, ¶ 6(2006); In re Donaldson Co., Inc, 16 F.3d 1189, 1193 (Fed. Cir. 
1994)(en banc). 
75 576 F.3d 1348 (Fed. Cir. 2009); see also supra notes 21-40 and accompanying text.  
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stored (i.e., a computer-readable medium).  As a result, such medical device 
patents can be written utilizing Beauregard claims rather than just method and 
apparatus claims.  By patenting the software on a tangible medium, rather than 
patenting the software as an intangible process, patent holders may be able to 
avoid limiting damages.76  Yet, a Beauregard style claim can capture scope that is 
often, at least arguably, as broad as a similar method claim.  In Cardiac, if the 
claim at issue had been a Beauregard claim reciting similar functional operations, 
then the plaintiff may not have been limited to damages for only those devices 
that could be shown to have actually performed the process.77  On the contrary, 
the plaintiff may have been able to collect damages from St. Jude as a direct 
infringer for every device that was sold that contained the set of software 
instructions capable of infringing the protected functionality. 
B. Question of Validity 
The validity of Beauregard claims has generally not been litigated in the years 
since the Federal Circuit affirmed the USPTO decision to make computer-
readable medium statutory subject matter in In re Beauregard.78  One case in 
particular Cybersource Corp. v. Retail Decisions, Inc.,79 one of the few cases that 
cites back to In re Beauregard,80 questioned the validity of the Beauregard 
holding itself.81  The Cybersource court stated that the “footing of the so-called 
Beauregard doctrine is anything but sure.”82  While this is a note of caution to the 
use of Beauregard claims, the lack of other litigation on validity implicates the 
opposite conclusion.83  More specifically, patent holders are asserting Beauregard 
claims,84 and the claims are being litigated to successful conclusions.85  The only 
major claim-related issue with the litigation asserting Beauregard-type claims 
seems to be focusing on general claim construction issues that have no relation to 
the fact that the claims are Beauregard claims.86 
                                                                                                                                     
76 See Finjan, 626 F.3d at 1197. See supra text accompanying notes 54-74. 
77 As discussed throughout the paper, the plaintiff would not have had to prove execution of 
the method, just sale of the ICD if using a Beauregard claim to obtain the protection instead of a 
method claim. 
78 53 F.3d 1583 (Fed. Cir. 1995). 
79 620 F.Supp.2d 1068 (N.D. Cal. 2009). 
80 53 F.3d 1583 (Fed. Cir. 1995). 
81 See Cybersource, 620 F.Supp.2d at 1078-79. 
82 Id. at 1079. 
83 See z4 Techs., Inc. v. Microsoft Corp., 507 F.3d 1340 (Fed. Cir. 2007); Finjan, Inc. v. 
Secure Computing Corp., 626 F.3d 1197, 1205 (Fed. Cir. 2010). 
84 See, e.g., Finjan, 626 F.3d 1197.  See also infra app. A. 
85 For examples of cases that include successful assertion of Beauregard claims with multi-
million dollar damage awards, see z4 Techs., 507 F.3d 1340; Finjan, 626 F.3d at 1205.  
86 See Oracle Corp. v. Parallel Networks, L.L.C., 375 Fed.Appx. 36, 2010 WL 1709308 (Fed. 
Cir. 2010). The Court of Appeals reversed a summary judgment finding by the district court which 
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The lack of litigation directly attacking Beauregard claims is a positive sign.  
The court in Cybersource suggested that the footing of Beauregard claims was 
unsure,87 making any litigation potentially troublesome.  However, the absence of 
such litigation suggests that these claims are valid and are not being challenged on 
the basis of citing non-statutory subject matter.  The only caveat with using this 
method of claiming, as evidenced by the litigation, is that the claim must be 
properly constructed.88 This is nothing new in practice, however, since the 
language of any claim must be carefully chosen to provide the most protection 
while safeguarding against the risk of invalidation during litigation.  The mere 
fact that it is a Beauregard claim apparently does not add to that issue. 
C. Assertion as a Dependent Claim 
While Beauregard claims are generally inserted as independent claims, they 
can also be inserted into a patent as dependent claims.89  In Schumer v. 
Laboratory Computer Systems, Inc., the Court of Appeals for the Federal Circuit 
overturned the district court's decision to treat a dependent Beauregard claim as 
invalid because the independent claim was determined to be invalid.90  The court 
reasoned that “when determining the validity of the claims of a patent, each claim 
must be separately considered.”91 The Schumer court based its decision on the 
idea that:  
Each claim of a patent (whether in independent, dependent, or 
multiple dependent form) shall be presumed valid independently of 
the validity of other claims; dependent or multiple dependent 
claims shall be presumed valid even though dependent upon an 
invalid claim.... The burden of establishing invalidity of a patent or 
any claim thereof shall rest on the party asserting invalidity.92  
Since a claim is scrutinized on its own it is important that the claim be 
carefully constructed.  If not, the issue that arises is one that came up in IPXL 
                                                                                                                                     
had found in favor of non-infringement. One of the claims asserted was a Beauregard claim, but 
the litigation focused on specific interpretation of a limitation within the claim. Id. See also IEX 
Corp. v. Blue Pumpkin Software, Inc., 122 Fed.Appx. 458 (Fed. Cir. 2005); Sw. Tech. 
Innovations, LLC v. Symantec Corp., C-09-1063 MMC, 2010 WL 1729405 (N.D. Cal. 2010); 
Irise v. Axure Software Solutions, Inc., CV 08-03601 SJO, 2009 WL 3615075 at *36 (C.D. Cal. 
2009). 
87 Cybersource Corp. v. Retail Decisions, Inc., 620 F.Supp.2d 1068 (N.D. Cal. 2009). 
88 See generally IEX Corp., 122 Fed.Appx. at 464 (following the standard procedures for 
claim construction and carefully analyzing the claim’s language). 
89  See Schumer v. Lab. Computer Sys., Inc., 308 F.3d 1304 (Fed. Cir. 2002). 
90 Id. 
91 Id. at 1316. 
92 Id. (citing 35 U.S.C. § 282 (2000)). 
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Holdings, LLC v. Amazon.com, Inc.93  In IPXL, the court held invalid a method 
claim that was dependent to a system claim because it was indefinite.94  The court 
held that drafting claims in this manner is indefinite because it is unclear whether 
infringement occurred when the system was created or when the method was 
actually executed.95  In light of the IPXL holding it is better practice to write 
Beauregard claims as independent claims, rather than as dependent claims. 
 
IV. CONCLUSION 
Method claims are used commonly in patents for software and computerized 
systems and devices.  Medical devices that include embedded software are often 
patented using both method claims and apparatus claims.  In an infringement suit, 
however, where the method claim is at issue and not the apparatus claim, patent 
holders risk losing a portion of the damages to which they are entitled.  It is clear 
that a properly drafted patent should cover a device that is merely capable of 
infringement when it comes to calculating damages or obtaining an injunction.  
To accomplish this, Beauregard claims can be used in patents covering these 
electromechanical devices so that any sale of a device would qualify as 
infringement.  By including Beauregard claims in device patents, patent holders 








                                                                                                                                     
93 IPXL Holdings, LLC v. Amazon.com, Inc., 430 F.3d 1377 (Fed. Cir. 2005). 
94 Id.  
95 Id. at 1384. 
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APPENDIX A: BEAUREGARD CLAIM TREND INFORMATION 
A. Application Statistics 
In the immediate period after In re Beauregard96 there was an abundant 
growth in the use of this style of claims.  The growth, however, has dropped off 
significantly in the last five years.  The last five years have seen a decline to a 
level that is similar to what it was in the period immediately following the case 




Figure 1 – The Calculated Number of Patent Applications Containing 
Beauregard Claims Between 1996 and 2010 
 
A method for pulling statistics had to be created in order to determine the 
frequency at which practitioners are submitting patent applications that include 
Beauregard claims.  The United States Patent office has a database that can be 
queried for specific language in the claims.  The time ranges were queried using 
claim language that is typical in a Beauregard claim and the results from each 
                                                                                                                                     
96 53 F.3d 1583 (Fed. Cir. 1995).  
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phase were combined to obtain the number of patents over each five-year period 
that contained these claims (See Table 1). 
 
Search Phrase Date Range Number of Patents 





































Table 1 – Breakdown of Search Phrases by Time Range and Resulting 
Number of Patent Applications 
B. Markman Hearing and Litigation Statistics 
 There has been a limited amount of litigation of Beauregard claims in the 
fifteen years since the decision was made.  In order to track the frequency with 
which Beauregard claims have been both asserted and litigated, a method of 
tracking was created.  Figure 2 shows a breakdown of the number of Markman97 
                                                                                                                                     
97 See Markman v. Westview Instruments Inc., 52 F.3d 967 (Fed. Cir. 1995). 
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hearings on a yearly basis, compared with the number of cases that have been 
litigated over the past fifteen years.  The search was based on Westlaw results on 
a query that was run for each year.98  The majority of the cases were decided in 




Figure 2 – Number of Markman Hearings and Trials for Patents Containing 
Beauregard Claims 
                                                                                                                                     
98 The following search string was used: “(READABLE +2 MEDI!) & da(aft 1/1/1996 & bef 
12/31/1996).”  The dates were adjusted and ran for each year between 1995 and 2010. The query 
was run in the Westlaw database containing only Markman hearings and then again in the Federal 
IP cases database to determine the number of cases being litigated. 
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APPENDIX B: BASIC CLAIM TYPES 
 
The United States Patent Act provides that an inventor may receive a patent 
for any new and useful process, machine, manufacture, or composition of 
matter.99  Descriptions of the different ways to claim devices that contain both 
software and hardware follow.  
A. Method Claims 
A method claim is used to reduce an invention to a series of steps or acts for 
performing a function to accomplish a result.  The Supreme Court held that a 
method, or process, is a mode of treatment of certain materials to produce a given 
result.100  Method claims define the invention in terms of what it does, or how it is 
done, as opposed to its structural definition.101  Method claims are ideal for 
patenting an invention that does not have a unique apparatus but still completes a 
unique process.  Because method claims focus on function rather than structure 
they are often the broadest type of claim that can be used for patenting 
software.102 
B. Apparatus Claims 
Apparatus claims are those claims that are tied directly to a device.  A typical 
apparatus claim describes the invention in terms of its components.  In this sense 
it is described in terms of what it is, not what it does.103  A more limiting type of 
apparatus claim is the means-plus-function apparatus claim. These claims 
describe the device in terms of what it does, not what it is.104  Apparatus claims 
are typically included along with method claims when there are both hardware 
and software components to an invention.105 
C. Computer-Readable Medium Claims 
Computer-readable medium claims are also known as Beauregard claims.106  
This type of claim allows for patenting software that is embedded onto a 
“computer-readable medium” such as a disk, CD, or other medium.  By using a 
Beauregard claim, the patent-holder protects itself from other manufacturers as 
                                                                                                                                     
99 35 U.S.C. § 101 (2006). 
100 Gottschalk v. Benson, 409 U.S. 63, 70 (1972). 
101 STEVEN W. LUNDBERG & STEPHEN C. DURANT, ELECTRONIC AND SOFTWARE PATENTS: 
LAW AND PRACTICE 6-16 (2nd ed. 2005). 
102 Id. at 6-28. 
103 Id. at 6-16. 
104 Id.  
105 Id. at 6-29. 
106 See In re Beauregard, 53 F.3d 1583 (Fed. Cir. 1995). 
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direct infringers rather than as contributory infringers.  This actually allows a 
software manufacturer to collect damages for infringement from a distributor of 
the computer-readable medium, rather than going after the end-user who is 
executing the software, which is often impractical or even impossible. 
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APPENDIX C: TYPES OF INFRINGEMENT 
Section 271 of the Patent Act defines the various types of patent 
infringement.107 A patent holder can accuse an infringer of violating its patent 
rights in three different ways: (1) directly infringing; (2) inducing infringement; 
or (3) contributing to infringement.  
A. Direct Infringement 
“Direct infringement” is defined as: 
[W]hoever without authority makes, uses, offers to sell, or sells any 
patented invention, within the United States or imports into the United 
States any patented invention during the term of the patent therefor, 
infringes the patent.108 
Under this rule, the patentee may bring an action against a defendant who 
commits acts that infringe.  “The making, using, or selling of a patented invention 
is the usual meaning of the expression 'direct infringement'.”109  However, when 
infringement is asserted for a patent that contains only method claims there is a 
different standard that must be followed.  “Method claims are only infringed 
when the claimed process is performed, not by the sale of an apparatus that is 
capable of infringing use."110 Thus the direct infringement of method claims 
happens when the end-user fully executes the process, and does not happen 
simply when the manufacturer sells a device that is capable of infringing. 
B. Indirect Infringement 
A patent holder may also sue for indirect infringement. There are two 
different types of indirect infringement: inducing infringement and contributory 
infringement. They are defined by 35 U.S.C. subsections 271(b) and (c) 
respectively. Indirect infringement (both inducing and contributory) is dependent 
on direct infringement existing as well.111 
1. Inducing Infringement 
Inducement of infringement is defined as “[w]hoever actively induces 
infringement of a patent shall be liable as an infringer.”112  In addition to direct 
                                                                                                                                     
107 See 35 U.S.C. § 271 (2006). 
108 35 U.S.C § 271(a) (2006). 
109 Joy Techs., Inc. v. Flakt, Inc., 6 F.3d 770, 773 (Fed. Cir. 1993). 
110 Ormco Corp. v. Align Tech., Inc., 463 F.3d 1299, 1311 (Fed. Cir. 2006). 
111 See Standard Havens Prods., Inc. v. Gencor Indus., Inc., 953 F.2d 1360, 1374 (Fed. Cir. 
1991). 
112 35 U.S.C. § 271(b) (2006). 
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infringement, for inducement of infringement there must be proof that the accused 
party actively and knowingly assisted an act of direct infringement.113 In a recent 
case, the Federal Circuit further held that an agency relationship or a contractual 
obligation to perform the claimed steps is required for two parties to be held 
jointly liable when the claim infringed is a method claim.114 
2. Contributory Infringement 
Contributory infringement is defined as: 
Whoever offers to sell or sells within the United States or imports 
into the United States a component of a patented machine, 
manufacture, combination or composition, or a material or apparatus 
for use in practicing a patented process, constituting a material part of 
the invention, knowing the same to be especially made or especially 
adapted for use in an infringement of such patent, and not a staple 
article or commodity of commerce suitable for substantial 
noninfringing use, shall be liable as a contributory infringer.115 
In order to prove contributory infringement, a patentee must prove that the 
defendant knew that the product was specifically made for use in infringing the 
patented method, and that the product sold to the direct infringer was a material 
part of the invention.116 
 
 
                                                                                                                                     
113 Water Techs. Corp. v. Calco, Ltd., 850 F.2d 660, 668 (Fed. Cir. 1988). 
114 See Akamai Techs., Inc. v. Limelight Networks, Inc., 629 F.3d 1311, 1320 (Fed. Cir. 
2010). 
115 35 U.S.C. § 271(c) (2006). 
116 See Veritas Operating Corp. v. Microsoft Corp., 562 F.Supp.2d 1141, 1157 (W.D. Wash. 
2008). 
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